{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:30:02Z","timestamp":1779100202536,"version":"3.51.4"},"reference-count":59,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2024.12505","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T11:18:07Z","timestamp":1711019887000},"source":"Crossref","is-referenced-by-count":2,"title":["Effects of total saikosaponins on CYP3A4 and CYP1A2 in HepaRG cells"],"prefix":"10.3892","volume":"27","author":[{"given":"Yunyan","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Affiliated Meitan People's Hospital of Zunyi Medical University, Zunyi, Guizhou 564100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfang","family":"Li","sequence":"additional","affiliation":[{"name":"The Key Laboratory of Clinical Pharmacy of Zunyi City, Zunyi Medical University, Zunyi, Guizhou 563006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Tang","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Medicine and Health, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, SK10 4TG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Hu","sequence":"additional","affiliation":[{"name":"The Key Laboratory of Clinical Pharmacy of Zunyi City, Zunyi Medical University, Zunyi, Guizhou 563006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Meitan People's Hospital of Zunyi Medical University, Zunyi, Guizhou 564100, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmiao","family":"Liu","sequence":"additional","affiliation":[{"name":"The Key Laboratory of Clinical Pharmacy of Zunyi City, Zunyi Medical University, Zunyi, Guizhou 563006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fushan","family":"Tang","sequence":"additional","affiliation":[{"name":"The Key Laboratory of Clinical Pharmacy of Zunyi City, Zunyi Medical University, Zunyi, Guizhou 563006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"key20240417132322_b1-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/13880209.2016.1262433","article-title":"A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applications","volume":"55","author":"Yuan","year":"2017","journal-title":"Pharm Biol"},{"issue":"114742","key":"key20240417132322_b2-ETM-27-5-12505","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114742","article-title":"A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K\/Akt\/mTOR pathway","volume":"283","author":"Zhang","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"key20240417132322_b3-ETM-27-5-12505","first-page":"110","article-title":"Research progress on Bupleurum marginatum var. stenophyllum","volume":"19","author":"Wang","year":"2019","journal-title":"World Latest Med Info"},{"key":"key20240417132322_b4-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.2042-7158.2010.01170.x","article-title":"Genus Bupleurum: A review of its phytochemistry, pharmacology and modes of action","volume":"63","author":"Ashour","year":"2011","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"key20240417132322_b5-ETM-27-5-12505","article-title":"A meta-analysis of clinical efficacy of the Dachaihu decoction plus hypoglycemic medicine on type 2 diabetes mellitus","volume":"14","author":"Liu","year":"2022","journal-title":"Clin J Chin Med"},{"key":"key20240417132322_b6-ETM-27-5-12505","first-page":"1673","article-title":"Meta-analysis of efficacy and safety of Chaihushugan decoction combined with antiepileptic drugs in treatment of epilepsy","volume":"8","author":"Li","year":"2020","journal-title":"Chin Arch Tradit Chin Med"},{"key":"key20240417132322_b7-ETM-27-5-12505","first-page":"62","article-title":"Meta-analysis of Xiaochaihu decoction combined with entecavir in the treatment of chronic viral hepatitis B","volume":"34","author":"Zhu","year":"2021","journal-title":"Western J Trad Chin Med"},{"issue":"713","key":"key20240417132322_b8-ETM-27-5-12505","article-title":"Effects of oral administration of minor Radix Buplenri granule on whole blood cyclosporin A concentration in kidney transplantation patients","volume":"19","author":"Zhou","year":"1999","journal-title":"Chin J Hosp Pharm"},{"key":"key20240417132322_b9-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1517\/phgs.4.4.387.22752","article-title":"P450 structures and oxidative metabolism of xenobiotics","volume":"4","author":"Lewis","year":"2003","journal-title":"Pharmacogenomics"},{"key":"key20240417132322_b10-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1742-7843.2005.pto_973160.x","article-title":"Assessment of CYP1A2 activity in clinical practice: Why, how, and when?","volume":"97","author":"Faber","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key20240417132322_b11-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1208\/s12248-012-9431-9","article-title":"In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substrates","volume":"15","author":"Goutelle","year":"2013","journal-title":"AAPS J"},{"key":"key20240417132322_b12-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"key20240417132322_b13-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bcp.2017.08.012","article-title":"The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p","volume":"145","author":"Chen","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"key20240417132322_b14-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20240417132322_b15-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/jat.3090","article-title":"HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening","volume":"35","author":"Wang","year":"2015","journal-title":"J Appl Toxicol"},{"key":"key20240417132322_b16-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1517\/17425255.2012.685159","article-title":"The HepaRG cell line: A unique in vitro tool for understanding drug metabolism and toxicology in human","volume":"8","author":"Andersson","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key20240417132322_b17-ETM-27-5-12505","first-page":"1038","article-title":"Research progress on the application of HepaRG cells in drug metabolism","volume":"38","author":"Li","year":"2019","journal-title":"Herald Med"},{"key":"key20240417132322_b18-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.2147\/DDDT.S268358","article-title":"Effects of saikosaponin D on CYP1A2 and CYP2D6 in HepaRG cells","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"key20240417132322_b19-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/bcpt.13552","article-title":"Effects of saikosaponin-D on CYP3A4 in HepaRG cell and protein-ligand docking study","volume":"128","author":"Li","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7-11.45","key":"key20240417132322_b20-ETM-27-5-12505","article-title":"A survey of the studies on saponins from Bupleurum in past 10 years","volume":"27","author":"Liu","year":"2002","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"key20240417132322_b21-ETM-27-5-12505","first-page":"545","article-title":"Research development on chemical compositions in Bupleurum chinense related with efficacy and toxicity","volume":"10","author":"Huang","year":"2013","journal-title":"Chin J Pharmacovigil"},{"key":"key20240417132322_b22-ETM-27-5-12505","first-page":"21","article-title":"Study on metabolic profiling of total saponins of Bupleurum chinense DC in Rats","volume":"46","author":"Wang","year":"2023","journal-title":"J Zunyi Med Uni"},{"key":"key20240417132322_b23-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/00498254.2016.1163753","article-title":"In vitro metabolism study of saikosaponin D and its derivatives in rat liver microsomes","volume":"47","author":"Yu","year":"2017","journal-title":"Xenobiotica"},{"key":"key20240417132322_b24-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1124\/dmd.112.048975","article-title":"Metabolism of saikosaponin A in rats: Diverse oxidations on the aglycone moiety in liver and intestine in addition to hydrolysis of glycosidic bonds","volume":"41","author":"Liu","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"key20240417132322_b25-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"key20240417132322_b26-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C (T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"e007956","key":"key20240417132322_b27-ETM-27-5-12505","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.007956","article-title":"Drug interactions affecting oral anticoagulant use","volume":"15","author":"Mar","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key20240417132322_b28-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans: An update","volume":"94","author":"Hakkola","year":"2020","journal-title":"Arch Toxicol"},{"key":"key20240417132322_b29-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.clpt.6100054","article-title":"Drug interaction studies: Study design, data analysis, and implications for dosing and labeling","volume":"81","author":"Huang","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"key20240417132322_b30-ETM-27-5-12505","first-page":"665","article-title":"Application progress in cytochrome P450 enzymes and research methods of drug metabolism","volume":"23","author":"Song","year":"2017","journal-title":"Med Recapitulate"},{"key":"key20240417132322_b31-ETM-27-5-12505","first-page":"740","article-title":"Effects of total saikosaponins on intestinal first-pass effect and CYP3A, CYP2E1","volume":"16","author":"Wang","year":"2011","journal-title":"Chin J Clin Pharm Ther"},{"key":"key20240417132322_b32-ETM-27-5-12505","first-page":"846","article-title":"Research overview of Xiaochuhu decoction combined with chemical drugs and their interaction","volume":"30","author":"Tang","year":"2019","journal-title":"China Pharm"},{"key":"key20240417132322_b33-ETM-27-5-12505","first-page":"15","article-title":"Comparison of pharmacokinetics between recombinant liver microsomes with CYP3A4 and CYP3A29","volume":"34","author":"Xue","year":"2015","journal-title":"Herald Med"},{"key":"key20240417132322_b34-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s10620-012-2555-z","article-title":"Alginate hydrogel as a potential alternative to hyaluronic acid as submucosal injection material","volume":"58","author":"Kang","year":"2013","journal-title":"Dig Dis Sci"},{"key":"key20240417132322_b35-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.taap.2015.12.020","article-title":"A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen","volume":"292","author":"Michaut","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20240417132322_b36-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2478\/10004-1254-60-2009-1885","article-title":"Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk","volume":"60","author":"Bozina","year":"2009","journal-title":"Arh Hig Rada Toksikol"},{"key":"key20240417132322_b37-ETM-27-5-12505","first-page":"660","article-title":"Toxicity evaluation of landfill leachate before and after SND\/UF\/RO treatment on HepG2 cells","volume":"41","author":"Liu","year":"2021","journal-title":"Acta Scientiae Circumstantiae"},{"key":"key20240417132322_b38-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2d and 3d in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch Toxicol"},{"key":"key20240417132322_b39-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vascn.2010.04.013","article-title":"HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro","volume":"63","author":"L\u00fcbberstedt","year":"2011","journal-title":"J Pharmacol Toxicol Methods"},{"key":"key20240417132322_b40-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.taap.2011.04.018","article-title":"Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with Jc-1 dye","volume":"254","author":"Pernelle","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20240417132322_b41-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3109\/00498254.2015.1118774","article-title":"Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells","volume":"46","author":"Sugiyama","year":"2006","journal-title":"Xenobiotica"},{"key":"key20240417132322_b42-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/toxsci\/kfs232","article-title":"Three-dimensional HepaRG model as an attractive tool for toxicity testing","volume":"130","author":"Leite","year":"2012","journal-title":"Toxicol Sci"},{"key":"key20240417132322_b43-ETM-27-5-12505","first-page":"380","article-title":"Biological characteristics and application of HepaRG cells","volume":"15","author":"Jiang","year":"2010","journal-title":"Chin Hepatol"},{"key":"key20240417132322_b44-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.17179\/excli2022-5033","article-title":"Okadaic acid influences xenobiotic metabolism in HepaRG cells","volume":"21","author":"Wuerger","year":"2022","journal-title":"EXCLI J"},{"key":"key20240417132322_b45-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13318-018-0533-3","article-title":"Advanced in vitro HepaRG culture systems for xenobiotic metabolism and toxicity characterization","volume":"44","author":"Ashraf","year":"2019","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"key20240417132322_b46-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00204-022-03329-8","article-title":"Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: Advantages and limitations","volume":"96","author":"Hammour","year":"2022","journal-title":"Arch Toxicol"},{"issue":"105389","key":"key20240417132322_b47-ETM-27-5-12505","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105389","article-title":"Study of the metabolic stability profiles of perampanel, rufinamide and stiripentol and prediction of drug interactions using HepaRG cells as an in vitro human model","volume":"82","author":"Meirinho","year":"2022","journal-title":"Toxicol In Vitro"},{"key":"key20240417132322_b48-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1124\/dmd.109.030197","article-title":"Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells","volume":"38","author":"Anth\u00e9rieu","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"key20240417132322_b49-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1568009622666220806121008","article-title":"Present and future prospects of the anti-cancer activities of saikosaponins","volume":"23","author":"Xiao","year":"2022","journal-title":"Curr Cancer Drug Targets"},{"issue":"940999","key":"key20240417132322_b50-ETM-27-5-12505","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.940999","article-title":"Therapeutic effects of total saikosaponins from Radix Bupleuri against Alzheimer\u2019s disease","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4950414","key":"key20240417132322_b51-ETM-27-5-12505","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4950414","article-title":"Total saikosaponins attenuates depression-like behaviors induced by chronic unpredictable mild stress in rats by regulating the PI3K\/AKT\/NF-\u039aappaB signaling axis","volume":"2022","author":"Zhou","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"issue":"117","key":"key20240417132322_b52-ETM-27-5-12505","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-018-2186-9","article-title":"Total saikosaponins of Bupleurum yinchowense reduces depressive, anxiety-like behavior and increases synaptic proteins expression in chronic corticosterine-treated mice","volume":"18","author":"Sun","year":"2018","journal-title":"BMC Complement Altern Med"},{"key":"key20240417132322_b53-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.phymed.2018.09.174","article-title":"A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins","volume":"50","author":"Li","year":"2018","journal-title":"Phytomedicine"},{"key":"key20240417132322_b54-ETM-27-5-12505","first-page":"693","article-title":"Research on total saponins of Radix Bupleuri regulating cytochrome P450 similar to Chaihushugan powder exerting antidepressant effects","volume":"39","author":"He","year":"2019","journal-title":"J Hunan Univ Tradit Chin Med"},{"issue":"588","key":"key20240417132322_b55-ETM-27-5-12505","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10020","article-title":"Effects of Xiaochaihu decoction on the expression of cytochrome P450s in rats","volume":"21","author":"Li","year":"2021","journal-title":"Exp Ther Med"},{"issue":"1044817","key":"key20240417132322_b56-ETM-27-5-12505","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1044817","article-title":"Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions","volume":"13","author":"Kong","year":"2023","journal-title":"Front Pharmacol"},{"key":"key20240417132322_b57-ETM-27-5-12505","first-page":"2710","article-title":"Effect of water extract from traditional Chinese medicines Rehmannia glutinosa, Scrophularia ningpoensis, Asparagus cochinchinensis and Ophiopogon japonicas on contents of CYP450 and activities of CYP3A, CYP2E1 and CYP1A2 in rat","volume":"36","author":"Wu","year":"2011","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"key20240417132322_b58-ETM-27-5-12505","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/1872312810666160719143703","article-title":"The uremic toxin indoxyl-3-sulfate induces CYP1A2 in primary human hepatocytes","volume":"10","author":"Liu","year":"2016","journal-title":"Drug Metab Lett"},{"key":"key20240417132322_b59-ETM-27-5-12505"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T10:56:27Z","timestamp":1713351387000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2024.12505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,21]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2024.12505","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"article-number":"217"}}